🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Newly Diagnosed Glioblastoma

A Phase 2 Study of the Ketogenic Diet vs Standard Anti-cancer Diet Guidance for Patients With Glioblastoma in Combination With Standard-of-care Treatment NCT05708352Phase 25 sites📍 Los Angeles📍 San Francisco📍 Santa Monica Cedars-Sinai Medical Center · Tests: Keto Diet, Standard Anti-Cancer Diet Lomustine in Addition to Standard of Care in Patients With MGMT Methylated Glioblastoma NCT06419946Phase 320 sites📍 Graz📍 Innsbruck📍 Linz Vastra Gotaland Region · Tests: Temozolomide, Lomustine Imaging Acetadote Metabolism in Glioblastoma NCT07387666EARLY Phase 11 site📍 Dallas University of Texas Southwestern Medical Center · Tests: Acetadote A Phase 1/2 Study of the Safety and Tolerability of MT-125 in GBM Patients NCT07185880Phase 1, Phase 23 sites📍 Phoenix📍 Jacksonville📍 Rochester Myosin Therapeutics Inc. · Tests: MT-125 Low-Intensity Oscillatory Magnetic Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme (GBM) - An Exposure-time Escalation Pilot Trial NCT06533163NA6 sites📍 Stuttgart📍 München📍 Bonn BioTex, Inc. · Tests: Oncomagnetic device Adjuvant Temozolomide ± 5-Aminolevulinic Acid + Low Intensity Diffuse Ultrasound Sonodynamic Therapy System for Newly Diagnosed Glioblastoma NCT07225621Phase 211 sites📍 Boston📍 Rochester📍 Albany Alpheus Medical, Inc. · Tests: 5-ALA HCl + LIDU SDT, Placebo + Sham SDT Intensified Adjuvant Therapy for High-Risk Newly Diagnosed Glioblastoma With Subtotal Resection or Short-Term Progression NCT07670026Phase 21 site📍 Hangzhou Second Affiliated Hospital, Zhejiang University, School of … · Tests: Sintilimab, Bevacizumab, Postoperative Radiotherapy, Temozolomide Temporally-Modulated Pulsed Radiation Therapy Versus Standard Radiation Therapy for the Treatment of Newly Diagnosed, IDH Wildtype, MGMT-Unmethylated Glioblastoma NCT07452458Phase 354 sites📍 Irvine📍 Los Angeles📍 Orange NRG Oncology · Tests: Biospecimen Collection, Computed Tomography, Magnetic Resonance Imaging, Questionnaire Administration, Radiation Therapy Carmustine Wafer in Combination With Retifanlimab and Radiation With/Without Temozolomide in Subjects With Glioblastoma NCT05083754Phase 11 site📍 Baltimore Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · Tests: Retifanlimab, Temozolomide, Radiation Therapy Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion NCT06333899EARLY Phase 118 sites📍 Aurora📍 Washington D.C.📍 Chicago Nationwide Children's Hospital · Tests: Lorlatinib, Lorlatinib with chemotherapy1, Lorlatinib with chemotherapy 2, Lorlatinib post Radiation BRiTE - Bispecific T Cell Engager for Patients With Glioblastoma NCT04903795Phase 11 site📍 Durham Mustafa Khasraw, MBChB, MD, FRCP, FRACP · Tests: hEGFRvIII-CD3 (BRiTE) TTFields General Routine Clinical Care in ndGBM Patients: a French Prospective Non-Interventional Study (TIGER France) NCT06924099n/a24 sites📍 Amiens📍 Avignon📍 Bordeaux NovoCure Ltd. WP1066 and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma NCT05879250Phase 22 sites📍 Chicago📍 Warrenville Northwestern University · Tests: Biospecimen Collection, Magnetic Resonance Imaging, Radiation Therapy, STAT3 Inhibitor WP1066, Surgical Procedure Vortioxetine for Newly Diagnosed Glioblastoma NCT07284628Phase 21 site📍 Zurich University of Zurich · Tests: Vortioxetine Study of Biologic Tumor and Plasma Biomarkers of Response to TTFields in Patients Treated for Newly Diagnosed Glioblastoma NCT06222138NA1 site📍 Toulouse Institut Claudius Regaud · Tests: The samples described below will be collected: Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care NCT07195591Phase 313 sites📍 Scottsdale📍 Los Angeles📍 Orlando GT Medical Technologies, Inc. · Tests: GammaTile®, External Beam Radiation Therapy, Temozolomide Music Therapy in Newly Diagnosed Glioblastoma After Chemoradiation Therapy (MELODY-GBM) NCT07375992NA1 site📍 Baltimore Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · Tests: Music intervention Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant NCT05843253Phase 220 sites📍 Aurora📍 Washington D.C.📍 Chicago Nationwide Children's Hospital · Tests: Ribociclib, Everolimus, Temozolomide (TMZ) Anterior Temporal Lobectomy in Temporal Glioblastoma NCT07021339Phase 31 site📍 Bonn University Hospital, Bonn · Tests: Anterior temporal lobectomy (ATL), Gross Total Resection (GTR) A Rollover Study of NBM-BMX in Combination With Temozolomide in Patients With Newly Diagnosed Glioblastoma NCT07569042Phase 1, Phase 23 sites📍 Kaohsiung City📍 Taichung📍 Taoyuan City Novelwise Pharmaceutical Corporation · Tests: NBM-BMX Capsule, Temozolomide D2C7-IT and 2141-V11 in Newly Diagnosed GBM Patients NCT05734560Phase 1, Phase 21 site📍 Durham Darell Bigner · Tests: D2C7-IT, 2141-V11 G-CSF After Chemo-radiation in Patients With Glioblastoma NCT06649851Phase 21 site📍 Boston Massachusetts General Hospital · Tests: Granulocyte Colony Stimulating Factor (G-CSF), Radiation Therapy + Temozolomide Study of Liposomal Curcumin in Combination With RT and TMZ in Patients With Newly Diagnosed High-Grade Gliomas NCT05768919Phase 1, Phase 22 sites📍 Washington D.C.📍 Baltimore SignPath Pharma, Inc. · Tests: Treatment Period 1, Treatment Period 2, Treatment Period 3, Treatment Period 4a Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII NCT07326566Phase 235 sites📍 Birmingham📍 Springdale📍 La Jolla Black Diamond Therapeutics, Inc. · Tests: silevertinib in combination with temozolomide, temozolomide (TMZ) A Study of RNA-lipid Particle (RNA-LP) Vaccines for Newly Diagnosed Pediatric High-Grade Gliomas (pHGG) and Adult Glioblastoma (GBM) NCT04573140Phase 12 sites📍 Washington D.C.📍 Gainesville University of Florida · Tests: Autologous total tumor mRNA and pp65 full length (fl) lysosomal associated membrane protein (LAMP) mRNA loaded DOTAP li… Neoadjuvant Chemoradiotherapy With or Without Concurrent Azeliragon in Patients With Newly Diagnosed Glioblastoma NCT06831526EARLY Phase 11 site📍 St Louis Washington University School of Medicine · Tests: Azeliragon, Temozolomide, Radiation therapy, Surgery or LITT Safety and Efficacy of L19TNF Plus Temozolomide Chemoradiotherapy in Patients With Newly Diagnosed Glioblastoma NCT04443010Phase 1, Phase 21 site📍 Zurich Philogen S.p.A. · Tests: Onfekafusp alfa, Temozolomide Ruxolitinib With Radiation and Temozolomide Compared to Radiation and Temozolomide for Newly Diagnosed Glioblastoma NCT06991101Phase 22 sites📍 Miami📍 New York Baptist Health South Florida · Tests: Ruxolitinib, Temozolomide, Radiation Therapy A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma NCT03970447Phase 2, Phase 363 sites📍 Birmingham📍 La Jolla📍 Los Angeles Global Coalition for Adaptive Research · Tests: Temozolomide, Lomustine, Regorafenib, Radiation, Paxalisib Chemoradiotherapy Versus Chemotherapy for Elderly and Frail GBM Patients NCT04765514Phase 22 sites📍 Calgary📍 Edmonton AHS Cancer Control Alberta · Tests: Temozolomide monotherapy, Chemo-Radiotherapy with concurrent temozolomide.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy